Lv41
550 积分 2023-04-10 加入
Bispecific antibodies: a mechanistic review of the pipeline
2小时前
待确认
Bioanalytical Challenges and Unique Considerations to Support Pharmacokinetic Characterization of Bispecific Biotherapeutics
5天前
已完结
Bimekizumab efficacy and safety in moderate to severe plaque psoriasis (BE READY): a multicentre, double-blind, placebo-controlled, randomised withdrawal phase 3 trial
21天前
已完结
Bimekizumab versus ustekinumab for the treatment of moderate to severe plaque psoriasis (BE VIVID): efficacy and safety from a 52-week, multicentre, double-blind, active comparator and placebo controlled phase 3 trial
21天前
已完结
Serum biomarker-based endotypes of atopic dermatitis in China and prediction for efficacy of dupilumab
1个月前
已完结
Treatment of chronic obstructive pulmonary disease: current pipeline and new opportunities
1个月前
已完结
Local and Systemic Inflammation in Patients with Chronic Obstructive Pulmonary Disease: Soluble Tumor Necrosis Factor Receptors Are Increased in Sputum
1个月前
已完结
Differences in Interleukin-8 and Tumor Necrosis Factor-Alpha in Induced Sputum From Patients With Chronic Obstructive Pulmonary Disease or Asthma
1个月前
已完结
Epithelial derived cytokines IL-25, IL-33 and TSLP in obstructive lung diseases
1个月前
已关闭
Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps
2个月前
已完结
皖公网安备34019202002308
